Bengaluru (PTI): ISRO on Saturday said it has transferred the IMS-1 Satellite Bus Technology to Alpha Design Technologies Pvt. Ltd in a step towards enhancing private industry participation in the country's space sector.
NewSpace India Limited (NSIL), the commercial arm of ISRO, facilitated the technology transfer through an agreement signed during an event held at the NSIL headquarters on August 2, the space agency said on its website.
The technology transfer documents were formally handed over by D Radhakrishnan, Chairman and Managing Director of NSIL to Col. H S Shankar (Retd.), Chairman and Managing Director of ADTL.
ADTL is one of the two private players identified to receive the transfer of this technology through Interest Exploratory Note (IEN) published by NSIL, it said.
This transfer marks the beginning of satellite bus technologies developed by ISRO being transferred to private industries. Further, the PSLV is under productionisation by a consortium of industries.
ISRO has been enabling private players to develop space technologies by facilitating and extending the expertise thus ensuring both out-bound and in-bound approaches.
The satellite bus, developed by ISRO's U R Rao Satellite Centre (URSC), is a versatile and efficient small satellite platform designed to facilitate low-cost access to space. The bus serves as a dedicated vehicle for various payloads, enabling earth imaging, ocean and atmospheric studies, microwave remote sensing, and space science missions while ensuring a quick turnaround time for satellite launches.
The IMS-1 bus, weighing about 100 kg, accommodates a 30kg payload. Solar arrays generate 330W power with a raw bus voltage of 30-42 V, ISRO said, adding it offers a 3-axis stabilised with four reaction wheels with a 1 Newton thruster that provides +/- 0.1 degree pointing accuracy.
It is a forerunner for IMS-2 bus technology, capable of improved features, and IMS-1 bus is utilised in previous ISRO missions like IMS-1, Youthsat and Microsat-2D, it said.
By transferring the IMS-1 technology to the private sector, ISRO/DoS (Department of Space) aims to bolster India's industrial growth in the space sector and foster technological self-reliance, it further said, adding the development opens up new avenues for private players to contribute to space research and exploration, in line with India's vision to expand its presence in the global space market.
Alpha Design Technologies Pvt. Ltd is an aerospace and defence company, with expertise in engineering, manufacturing, and system integration. It has been a key player in various projects related to defence, space and homeland security, contributing significantly to India's technological progress in these domains.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi, Feb 25 (PTI): The Supreme Court on Tuesday asked the Centre to respond on the possibility of framing a policy over the adverse effects, including deaths, of COVID-19 vaccination after being informed about the absence of any such scheme on compensation.
A bench comprising Justices Vikram Nath and Sandeep Mehta was informed by the Centre, represented by additional solicitor general Aiashwarya Bhati, that the pandemic was declared a disaster and the adverse effects following immunisation (AEFI) including the deaths were not covered under it and there was no policy for compensation in such cases.
The bench, however, said that COVID-19 deaths and vaccine-related deaths should not be viewed in isolation.
"Ultimately, the entire vaccination drive was a response to the pandemic. You cannot say they are not interlinked," it said.
The law officer said there was no policy under the Disaster Management Act to deal with the AEFI following the COVID-19 immunisation.
"The COVID-19 was declared a disaster, but the vaccination drive was conducted as per the medical protocol. The AEFI mechanism assesses whether a death is directly linked to the vaccine," she said.
Bhati sought three weeks to respond to the court’s suggestion which was allowed by the bench, which posted the appeal of the Centre against a Kerala High Court order for hearing on March 18.
One Sayeeda K A, whose husband died allegedly due to the side effects of COVID vaccine, moved the Kerala High Court seeking compensation.
It was alleged that there was no specific policy to deal with the AEFI.
The high court had ordered the National Disaster Management Authority to frame a policy for identifying cases of death due to the after-effects of the COVID-19 immunisation to pay the compensation to the kith and kin of the deceased.
The top court took note of the appeal of the Centre and stayed the high court’s decision in 2023.
The Serum Institute of India, which manufactured one of the COVID-19 vaccines, has also filed a transfer petition.